Respiratory syncytial virus (RSV) vaccine

Study

Respiratory syncytial virus (RSV) vaccine under study

 

Respiratory syncytial virus (RSV) is a highly contagious seasonal lung infection. It is a common disease that can affect people of all ages, but in this case, it focuses more particularly on older people.

Most cases are mild, with symptoms similar to those of a common cold, therefore in some cases the infection can be severe, leading to lung diseases such as pneumonia for example.

People over 65 and those of all ages who have heart or lung problems or a weakened immune system are particularly at risk. RSV can also make existing heart and lung problems worse.

We are conducting a study that evaluates the safety and consistency of a vaccine under study for preventing RSV infections. We are conducting this study to support the development of an RSV vaccine for people 65 years of age and older, a target population at higher risk.

To participate, you must:

  • Be 65 years of age and over
  • Have good general health

 

You will be given a reimbursement for study-related expenses when you participate in the clinical study and you will be surrounded by a medical team throughout the process.

I want to apply to this clinical study

JolietteQuébecSherbrookeVictoriaville

For more information, contact us at
579 841-0571 (Joliette), 581 477-3439 (Québec), 819 346-2887 (Sherbrooke), 819 260-1172 (Victoriaville)
or at 1-844-739-3439 (toll free), or fill the online form.

The study process in pictures

Explanation

Step 1 | Before starting the study, we will take time to fully explain the selection process and the conduct of the study by phone.

Meeting

Step 2 | After the initial phone interview, if you are still interested in taking part in a study, we schedule a preliminary meeting with you during which you may ask all the questions you wish and take the time you require to read over the consent form. This form explains, in detail, the different stages of each study.

Decision

Step 3 | You may make a decision at that time to move forward with or terminate the selection process. However, you are under no obligation to make an immediate decision. Based on briefing content, you may take the time necessary to come to a decision and consult with your personal physician or loved ones.

Tests

Step 4 | Depending on the nature of the study, some tests or medical examinations may be required. In the majority of cases, these tests or examinations are conducted on Diex Research premises based on your individual availability.

Departure

Step 5 | If you are eligible, you may then begin a clinical study with us.